• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的病毒疗法。

Virotherapy in cancer.

作者信息

Motalleb Gholamreza

机构信息

Dept. of Biology, Faculty of Science, University of Zabol, Zabol, Iran.

出版信息

Iran J Cancer Prev. 2013 Spring;6(2):101-7.

PMID:25250118
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4142919/
Abstract

New cancer therapies with novel mechanisms and functions are needed to treatpatients with different cancers. Virotherapy is a good scenario for such treatment. The advantages of virotherapy include the potential lack of cross resistance with standard therapies and the ability to cause tumor destruction by numerous mechanisms. Oncolytic virus not only possesses unique mechanisms of action that are distinct from other treatment modalities, its self-perpetuating nature provides an ideal platform for therapeutic transgenic insertion. In this review article, a variety of oncolytic viruses in cancer gene therapy will be described.

摘要

需要具有新颖机制和功能的新型癌症疗法来治疗不同癌症患者。病毒疗法是这种治疗的一个良好方案。病毒疗法的优点包括可能与标准疗法不存在交叉耐药性,以及能够通过多种机制导致肿瘤破坏。溶瘤病毒不仅具有与其他治疗方式不同的独特作用机制,其自我增殖的特性为治疗性转基因插入提供了理想平台。在这篇综述文章中,将描述癌症基因治疗中多种溶瘤病毒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a7b/4142919/0a91b17ae4c3/IJCP-06-101f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a7b/4142919/5cedddf74a4d/IJCP-06-101f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a7b/4142919/2fa9b2301642/IJCP-06-101f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a7b/4142919/0a91b17ae4c3/IJCP-06-101f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a7b/4142919/5cedddf74a4d/IJCP-06-101f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a7b/4142919/2fa9b2301642/IJCP-06-101f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a7b/4142919/0a91b17ae4c3/IJCP-06-101f3.jpg

相似文献

1
Virotherapy in cancer.癌症中的病毒疗法。
Iran J Cancer Prev. 2013 Spring;6(2):101-7.
2
Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-Lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-Derived Mouse Melanoma Model.新型溶瘤单纯疱疹病毒 1 VC2 在免疫活性 B16F10 衍生的小鼠黑素瘤模型中促进持久的、全身性抗黑素瘤肿瘤免疫反应和提高生存率。
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01359-20.
3
Oncolytic adenoviruses for cancer gene therapy.用于癌症基因治疗的溶瘤腺病毒
Methods Mol Biol. 2008;433:243-58. doi: 10.1007/978-1-59745-237-3_15.
4
Development of oncolytic viruses for cancer therapy.溶瘤病毒在癌症治疗中的发展。
Transl Res. 2021 Nov;237:98-123. doi: 10.1016/j.trsl.2021.04.008. Epub 2021 Apr 24.
5
Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions.基于干细胞的靶向溶瘤病毒疗法细胞载体:转化机遇与待解问题
Viruses. 2015 Nov 27;7(12):6200-17. doi: 10.3390/v7122921.
6
Targeting pediatric cancer stem cells with oncolytic virotherapy.用溶瘤病毒疗法靶向小儿癌干细胞。
Pediatr Res. 2012 Apr;71(4 Pt 2):500-10. doi: 10.1038/pr.2011.58. Epub 2012 Feb 15.
7
Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses.溶瘤病毒治疗作为一种有前途的癌症免疫疗法:溶瘤病毒耐药的机制。
Future Oncol. 2022 Jan;18(2):245-259. doi: 10.2217/fon-2021-0802. Epub 2021 Nov 25.
8
Lung cancer and oncolytic virotherapy--enemy's enemy.肺癌与溶瘤病毒疗法——敌人的敌人
Transl Oncol. 2023 Jan;27:101563. doi: 10.1016/j.tranon.2022.101563. Epub 2022 Oct 14.
9
Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.治疗性干细胞和溶瘤病毒疗法用于转移性癌症治疗的先进新策略。
Oncotarget. 2016 Sep 6;7(36):58684-58695. doi: 10.18632/oncotarget.11017.
10
Oncolytic Virotherapy.溶瘤病毒治疗。
Cancer Treat Res. 2023;185:105-126. doi: 10.1007/978-3-031-27156-4_7.

引用本文的文献

1
The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus.病毒敲门:用溶瘤新城疫病毒改善癌症治疗
Life (Basel). 2023 Jul 26;13(8):1626. doi: 10.3390/life13081626.
2
Comparison of the Effect of Adipose Mesenchymal Stem Cells-Derived Secretome with and without Reovirus in CT26 Cells.脂肪间充质干细胞分泌组联合呼肠孤病毒与单纯联合呼肠孤病毒对 CT26 细胞的作用比较。
Arch Razi Inst. 2022 Apr 30;77(2):615-622. doi: 10.22092/ARI.2021.353845.1615. eCollection 2022 Apr.
3
Live-attenuated poliovirus-induced extrinsic apoptosis through Caspase 8 within breast cancer cell lines expressing CD155.

本文引用的文献

1
Multiscale model for the effects of adaptive immunity suppression on the viral therapy of cancer.自适应免疫抑制对癌症病毒治疗影响的多尺度模型。
Phys Biol. 2013 Apr;10(2):025005. doi: 10.1088/1478-3975/10/2/025005. Epub 2013 Mar 15.
2
Intelligent design: combination therapy with oncolytic viruses.智能设计:溶瘤病毒联合治疗。
Mol Ther. 2010 Feb;18(2):251-63. doi: 10.1038/mt.2009.283. Epub 2009 Dec 22.
3
Targeting cancer-initiating cells with oncolytic viruses.用溶瘤病毒靶向肿瘤起始细胞。
表达 CD155 的乳腺癌细胞系中,活减脊灰病毒通过 Caspase 8 诱导外在细胞凋亡。
Breast Cancer. 2022 Sep;29(5):899-907. doi: 10.1007/s12282-022-01372-y. Epub 2022 Jun 1.
4
Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo.表达白细胞介素-12的重组新城疫病毒株rAF-IL12对CT26结肠癌细胞的体外和体内细胞毒性研究。
Cancer Cell Int. 2020 Jun 29;20:278. doi: 10.1186/s12935-020-01372-y. eCollection 2020.
5
Learning-accelerated discovery of immune-tumour interactions.学习加速的免疫-肿瘤相互作用发现
Mol Syst Des Eng. 2019 Aug 1;4(4):747-760. doi: 10.1039/c9me00036d. Epub 2019 Jun 7.
6
Oral poliovirus vaccine-induced programmed cell death involves both intrinsic and extrinsic pathways in human colorectal cancer cells.口服脊髓灰质炎病毒疫苗诱导的程序性细胞死亡涉及人类结肠癌细胞的内在和外在途径。
Oncolytic Virother. 2018 Oct 30;7:95-105. doi: 10.2147/OV.S177260. eCollection 2018.
7
Hepatitis C virus and vaccine development.丙型肝炎病毒与疫苗研发
Int J Mol Cell Med. 2014 Fall;3(4):207-15.
Mol Ther. 2009 Oct;17(10):1677-82. doi: 10.1038/mt.2009.193. Epub 2009 Aug 11.
4
Oncolytic viruses: time to compare, contrast, and combine? 5th international meeting on replicating oncolytic virus therapeutics. Banff, Alberta, Canada, 18-22 March 2009.溶瘤病毒:是时候进行比较、对比与结合了?第五届溶瘤病毒治疗复制国际会议。2009年3月18日至22日,加拿大艾伯塔省班夫
Mol Ther. 2009 Jun;17(6):934-5. doi: 10.1038/mt.2009.86.
5
Production and in vivo applications of gene transfer vectors. Preface.基因转移载体的生产及体内应用。前言。
Methods Mol Biol. 2008;433:v-vi.
6
Oncolytic virotherapy.溶瘤病毒疗法
Ann Hepatol. 2008 Jan-Mar;7(1):34-45.
7
Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells.组织蛋白酶的胞质激活介导细小病毒H-1诱导的顺铂和TRAIL抗性胶质瘤细胞的杀伤。
J Virol. 2007 Apr;81(8):4186-98. doi: 10.1128/JVI.02601-06. Epub 2007 Feb 7.
8
Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells.溶瘤病毒疗法与信号抑制剂的协同作用:雷帕霉素增强黏液瘤病毒对人肿瘤细胞的嗜性。
J Virol. 2007 Feb;81(3):1251-60. doi: 10.1128/JVI.01408-06. Epub 2006 Nov 15.
9
Oncolytic potential of rodent parvoviruses for cancer therapy in humans: a brief review.啮齿动物细小病毒在人类癌症治疗中的溶瘤潜力:简要综述
J Vet Med B Infect Dis Vet Public Health. 2005 Sep-Oct;52(7-8):327-30. doi: 10.1111/j.1439-0450.2005.00877.x.
10
Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.黏液瘤病毒是一种新型溶瘤病毒,对实验性人类胶质瘤具有显著的抗肿瘤活性。
Cancer Res. 2005 Nov 1;65(21):9982-9990. doi: 10.1158/0008-5472.CAN-05-1201.